Healthcare provider profile · identity verified

George A Cook, MD

Allopathic & Osteopathic Physicians|Family Medicine · CANADIAN, TX · NPI 1518959147

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show George A Cook, MD received $45.49 in general payments during 2025 across 2 reported records.

Astellas Pharma US Inc accounted for 70.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$45.49

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Astellas Pharma US Inc	Unresolved — no canonical attribution shown	$31.96	70.3%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$13.53	29.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$45.49	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Veozah Normalized: veozah	Drug	Astellas Pharma US Inc	$31.96	1	2025
Source payment records 2025-08-14 · Astellas Pharma US Inc · $31.96 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$13.53	1	2025
Source payment records 2025-08-21 · Exact Sciences Corporation · $13.53 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	342	72
Gabapentin	Gabapentin	326	64
Atorvastatin Calcium	Atorvastatin Calcium	290	64
Pantoprazole Sodium	Pantoprazole Sodium	273	45
Potassium Chloride	Potassium Chloride	257	45
Metformin Hcl Er	Metformin Hcl	226	47
Lisinopril	Lisinopril	211	42
Furosemide	Furosemide	209	42
Losartan Potassium	Losartan Potassium	209	47
Metoprolol Succinate	Metoprolol Succinate	198	44
Amlodipine Besylate	Amlodipine Besylate	185	40
Tamsulosin Hcl	Tamsulosin Hcl	173	32
Hydrochlorothiazide	Hydrochlorothiazide	145	37
Duloxetine Hcl	Duloxetine Hcl	142	24
Tramadol Hcl	Tramadol Hcl	142	30
Allopurinol	Allopurinol	139	26
Simvastatin	Simvastatin	135	24
Omeprazole	Omeprazole	132	30
Rosuvastatin Calcium	Rosuvastatin Calcium	130	30
Escitalopram Oxalate	Escitalopram Oxalate	129	23
Carvedilol	Carvedilol	116	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	28
Quetiapine Fumarate	Quetiapine Fumarate	91	17
Clopidogrel	Clopidogrel Bisulfate	86	21
Metoprolol Tartrate	Metoprolol Tartrate	86	14
Montelukast Sodium	Montelukast Sodium	86	17
Ozempic	Semaglutide	83	12
Spironolactone	Spironolactone	81	22
Eliquis	Apixaban	80	16
Synthroid	Levothyroxine Sodium	79	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	70	29
Xarelto	Rivaroxaban	70	suppressed
Glipizide Er	Glipizide	65	12
Trazodone Hcl	Trazodone Hcl	64	14
Lorazepam	Lorazepam	62	suppressed
Prednisone	Prednisone	60	21
Sertraline Hcl	Sertraline Hcl	57	11
Finasteride	Finasteride	56	suppressed
Pregabalin	Pregabalin	55	12
Donepezil Hcl	Donepezil Hcl	53	suppressed
Alprazolam	Alprazolam	50	13
Cefdinir	Cefdinir	50	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Jardiance	Empagliflozin	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Metformin Hcl	Metformin Hcl	42	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Trulicity	Dulaglutide	41	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Ezetimibe	Ezetimibe	40	suppressed
Azithromycin	Azithromycin	39	34
Lantus	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Atenolol	Atenolol	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Meloxicam	Meloxicam	37	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	21
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Temazepam	Temazepam	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Levetiracetam	Levetiracetam	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	29	20
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Ramipril	Ramipril	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Carbamazepine Er	Carbamazepine	19	suppressed
Cartia Xt	Diltiazem Hcl	19	suppressed
Famotidine	Famotidine	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Fluconazole	Fluconazole	17	11
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Diazepam	Diazepam	16	suppressed
Estradiol	Estradiol	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Dapsone	Dapsone	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er Pm	Verapamil Hcl	13	suppressed
Xanax	Alprazolam	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Nystatin	Nystatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Diflucan	Fluconazole	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$45.49 · 2 records	Astellas Pharma US Inc	Cologuard Collection Kit, Veozah	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error